Is decreased use of analgesics in Alzheimer disease due to a change in the affective component of pain?

Alzheimer Disease and Associated Disorders

Volumn 11, Issue 3, 1997, Pages 171-174

  Scherder, Erik J A ^a,b   Bouma, Anke ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b NONE   (Netherlands)

Author keywords

Affective disorders; Alzheimer disease; Analgesics; Pain

Indexed keywords

ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

AFFECTIVE NEUROSIS; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG USE; HUMAN; HYPOTHESIS; LIMBIC CORTEX; MAJOR CLINICAL STUDY; PAIN; PRIORITY JOURNAL; SELF REPORT;

EID: 0030884467     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-199709000-00010     Document Type: Article

References (20)

1. Bishop B. Pain: its physiology and rationale for management. Part I. Neuroanatomical substrate of pain. Phys Ther 1980;60:13-20.
2. Coderre TJ, Katz J, Vaccarino AL, Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 1993;52:259-85.
3. Ferrell BA. Pain evaluation and management in the nursing home. Ann Intern Med 1995;123:681-7.
4. Ferrell BA, Ferrell BR, Osterweil D. Pain in the nursing home. J Am Geriatr Soc 1990;38:409-14.
5. Graeff FG. Neuroanatomy and neurotransmitter regulation of defensive behaviors and related emotions in mammals. Braz J Med Biol Res 1994;27:811-29.
6. Heyman A, Wilkinson WE, Stafford JA, Helms MJ, Sigmon AH, Weinberg T. Alzheimer's disease: a study of epidemiological aspects. Ann Neurol 1984;15:335-41.
7. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-72.
8. Lucca U, Tettamanti M, Forloni G, Spagnoli A. Nonsteroidal antiinflammatory drug use in Alzheimer's disease. Biol Psychiatry 1994;36:854-6.
9. Marzinski LR. The tragedy of dementia: clinically assessing pain in the confused, nonverbal elderly. J Gerontol Nurs 1991;17:25-8.
10. McDowell I, Hill G, Lindsay J, et al. The Canadian study of health and aging: risk factors for Alzheimer's disease in Canada. Neurology 1994;44:2073-80.
11. McGeer PL, McGeer E, Rogers J, Sibley J. Anti-inflammatory drugs and Alzheimer disease. Lancet 1990;335:1037.
12. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: reports of the NINCDS-ADRDA workgroup under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
13. Norusis MJ. Statistical package for the social sciences, SPSS/PC+. New York: McGraw-Hill, 1988.
14. Parmelee PA, Smith B, Katz IR. Pain complaints and cognitive status among elderly institution residents. J Am Geriatr Soc 1993;41:517-22.
15. Reisberg B, Ferris SH, De Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1136-9.
16. Reisberg B, Franssen E, Sclan SG, Kluger A, Ferris SH. Stage specific incidence of potentially remediable behavioral symptoms in aging and Alzheimer disease. A study of 120 patients using the BEHAVE-AD. Bull Clin Neurosci 1989;54:95-112.
17. Saper CB. Chemical neuroanatomy of Alzheimer's disease. In: Iversen LL, Iversen SD, Snijder SH, eds. Handbook of psychopharmacology. New York: Plenum Press, 1988:131-56.
18. Semla TP, Cohen D, Paveza G, et al. Drug use patterns of persons with Alzheimer's disease and related disorders living in the community. J Am Geriatr Soc 1993;41:408-13.
19. Swaab DF, Hofman MA, Lucassen PJ, Purba JS, Raadsheer FC, Van de Nes JAP. Functional neuroanatomy and neuropathology of the human hypothalamus. Anal Embryol 1993;187:317-30.
20. Vreeling FW, Houx PJ, Jolles J, Verhey FR. Primitive reflexes in Alzheimer's disease and vascular dementia. J Geriatr Psychiatry Neurol 1995;8:111-7.